Sunday, July 6, 2025

Equitable and Ethical Access to Investigational Cell and Gene Therapies: Key Insights from ISCT Position Paper #sciencefather #researcher #gene therapies

 ๐Ÿ”ฌ Expanded Access to Cell & Gene Therapies: Bridging Hope and Regulation ๐Ÿงฌ

In the rapidly evolving world of cell and gene therapy, patients with serious or life-threatening conditions often face a harsh reality — they need treatment now, not years from now. For those who cannot join clinical trials and have no approved alternatives, the Expanded Access (EA) pathway offers a critical lifeline. ๐Ÿ’‰⚖️

Spearheaded by the International Society for Cell & Gene Therapy’s Expanded Access Working Group, a recent position paper sheds light on how investigational therapies can be made available outside of trials. These therapies are often custom-made (or “bespoke”) and hold potentially curative promise — making access a matter of urgency for many patients. ๐Ÿง‘‍⚕️๐Ÿ’ก



๐Ÿ’ญ Why Expanded Access Matters

  • Many cell and gene therapies target rare or incurable diseases.

  • Clinical trials may not be accessible to everyone due to geography, eligibility, or timing.

  • Expanded Access allows compassionate use of unapproved treatments under regulatory oversight.

  • Patient communication must be honest and transparent ๐Ÿ—ฃ️

  • Data collection from EA cases can inform future research ๐Ÿ“Š

  • Cost recovery models must be designed with long-term access and affordability in mind ๐Ÿ’ฐ

  • Equity and inclusion should guide every access decision ๐Ÿค๐ŸŒ

  • Collaboration with regulators is essential to ensure compliance and patient safety ๐Ÿ›️๐Ÿ”

  • Education for clinicians and patients is crucial to raise awareness about EA pathways ๐Ÿ“š๐Ÿ‘จ‍๐Ÿซ

๐Ÿงญ Moving Forward

As this field advances, we must ensure that the promise of innovation doesn’t widen the gap in access. Regulatory frameworks must evolve in step with science, always keeping the patient's well-being at the center. ❤️

This position paper serves as a vital resource for clinicians, researchers, and policymakers navigating the grey zones of investigational treatment. It calls for ethical, equitable, and science-backed pathways to deliver these powerful therapies where they’re needed most.


Scientific World Research Awards๐Ÿ†

Visit our page : https://scientificworld.net/

Nominations page๐Ÿ“ƒ : https://scientificworld.net/award-nomination/?ecategory=Awards&rcategory=Awardee

Get Connects Here:

==================

Youtube: https://www.youtube.com/@Scientificresearch-04

Instagram : https://www.instagram.com/swr_awards/

Blogger :https://www.blogger.com/blog/posts/8295489504259175195?hl=en&tab=jj

Twitter :https://x.com/SWR_Awards

Tumblr: https://www.tumblr.com/blog/scientificworldresearch

What'sApp: https://whatsapp.com/channel/0029Vb5WOsUH5JLpZ1w0RD2M 


No comments:

Post a Comment

A methodology for the integration of fire risk in building life cycle analysis #sciencefather #researcherawards #fire

  Integrating Fire Risk into Building Life Cycle Analysis Understanding fire risk is essential for creating safer, more resilient, and sust...